A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

Afficher d'autres versions (1)

Détails bibliographiques
Auteurs principaux:	van Leeuwen, N, Nijpels, G, Becker, M, Deshmukh, H, Zhou, K, Stricker, B, Uitterlinden, A, Hofman, A, van 't Riet, E, Palmer, C, Guigas, B, Slagboom, P, Durrington, P, Calle, R, Neil, A, Hitman, G, Livingstone, S, Colhoun, H, Holman, R, McCarthy, M, Dekker, J, 't Hart, L, Pearson, E
Format:	Journal article
Publié:	2012

Documents similaires

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts.
par: van Leeuwen, N, et autres
Publié: (2012)

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of two Dutch and two UK cohorts
par: 't Hart, L, et autres
Publié: (2011)

The role of ATM in response to metformin treatment and activation of AMPK.
par: Zhou, K, et autres
Publié: (2012)

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
par: Colhoun, H, et autres
Publié: (2005)

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke
par: Newman, C, et autres
Publié: (2005)

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
par: Thomason, M, et autres
Publié: (2004)

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
par: Hitman, G, et autres
Publié: (2007)

Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS)
par: DeMicco, D, et autres
Publié: (2005)

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
par: Neil, H, et autres
Publié: (2006)

Effect of atorvastatin on stroke in patients with type 2 diabetes: factors predicting the risk of stroke in the Collaborative Atorvastatin Diabetes Study (CARDS)
par: Hitman, G, et autres
Publié: (2005)

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
par: Colhoun, H, et autres
Publié: (2009)

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
par: Colhoun, H, et autres
Publié: (2011)

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
par: Raikou, M, et autres
Publié: (2007)

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
par: Colhoun, H, et autres
Publié: (2004)

Change in Lp-PLA2 With Risk Change on Statin Therapy in the Collaborative Atorvastatin Diabetes Study (CARDS)
par: Betteridge, D, et autres
Publié: (2009)

Role of Mitochondria in the Mechanism(s) of Action of Metformin
par: Guillaume Vial, et autres
Publié: (2019-05-01)

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.
par: Zhou, K, et autres
Publié: (2014)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
par: Zhou, K, et autres
Publié: (2011)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
par: Zhou, K, et autres
Publié: (2011)

Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS)
par: Charlton-Menys, V, et autres
Publié: (2009)

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.
par: Colhoun, H, et autres
Publié: (2002)

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
par: Charlton-Menys, V, et autres
Publié: (2009)

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
par: Charlton-Menys, V, et autres
Publié: (2009)

Heritability of variation in glycaemic response to metformin: A genome-wide complex trait analysis
par: Zhou, K, et autres
Publié: (2014)

Cost-effectiveness of atorvastatin (10mg) in patients with type 2 diabetes without coronary heart disease: CARDS trial analysis and extrapolation
par: Raikou, M, et autres
Publié: (2005)

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
par: Newman, C, et autres
Publié: (2008)

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS)
par: Newman, C, et autres
Publié: (2006)

C-reactive Protein and Amyloid A as Predictors of Cardiovascular Events in Type 2 Diabetes in CARDS
par: Charlton-Menys, V, et autres
Publié: (2009)

Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.
par: Mahvash Zakikhani, et autres
Publié: (2012-01-01)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
par: Soedamah-Muthu, S, et autres
Publié: (2003)

Metformin and mortality. Reply to Lund SS [letter]
par: Stevens, R, et autres
Publié: (2013)

Metformin and mortality. Reply to Lund SS [letter].
par: Stevens, R, et autres
Publié: (2013)

The effect of atorvastatin therapy on tumour necrosis factor-α and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart disease
par: Soedamah-Muthu, S, et autres
Publié: (2011)

Metformin and risk of cardiovascular disease.
par: Turner, R, et autres
Publié: (1999)

Risk of anaemia with long-term metformin use in a community setting
par: Donnelly, L, et autres
Publié: (2017)

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes
par: Preiss, D, et autres
Publié: (2016)

ANALISIS TERHADAP PERLINDUNGAN HUKUM BAGI NASABAH PENGGUNA ATM (SKIMMING KARTU ATM PADA MESIN ATM BANK X)
par: , Ronald Arthur Saiya, et autres
Publié: (2014)

Identifying the Latitude and Longitude of ATMs in ATM Networks
par: Niloofar Haghjoo, et autres
Publié: (2024-06-01)

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
par: Elisabet Cuyàs, et autres
Publié: (2019-03-01)

METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
par: Holman, R, et autres
Publié: (1989)